Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Joyce

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
JAMA Network Open|January 26, 2021
Association of Out-of-Pocket Spending With Insulin Adherence in Medicare Part DErin Trish, Katrina Kaiser, Geoffrey Joyce
Health Affairs (Project Hope)|November 5, 2014
Specialty drug spending trends among Medicare and Medicare Advantage enrollees, 2007-11Erin Trish, Geoffrey Joyce, Dana P Goldman
JAMA Network Open|August 1, 2025
Formulary Restrictions and Relapse Episodes in Persons With Relapsing-Remitting Multiple SclerosisBarbara Blaylock, Karen Van Nuys, Geoffrey Joyce
Obstetrics and Gynecology|March 23, 2011
Association between the birth of twins and parental divorceAnupam B Jena, Dana P Goldman, Geoffrey Joyce
Kidney International|September 17, 2005
Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?Christopher S Saigal, Geoffrey Joyce, Anga R Timilsina, et al.
The American Journal of Managed Care|August 18, 2017
The price may not be right: the value of comparison shopping for prescription drugsSanjay Arora, Neeraj Sood, Sophie Terp, et al.
The American Journal of Managed Care|October 17, 2022
Formulary restrictions and stroke risk in patients with atrial fibrillationBo Zhou, Seth Seabury, Dana Goldman, et al.
JAMA Internal Medicine|July 11, 2017
Physician Reimbursement in Medicare Advantage Compared With Traditional Medicare and Commercial Health InsuranceErin Trish, Paul Ginsburg, Laura Gascue, et al.
Health Affairs (Project Hope)|March 4, 2024
Medicare Part D Plans Greatly Increased Utilization Restrictions On Prescription Drugs, 2011-20Geoffrey Joyce, Barbara Blaylock, Jiafan Chen, et al.
Journal of Health Politics, Policy and Law|July 22, 2022
Reforming the Medicare Part D Benefit Design: Financial Implications for Beneficiaries, Private Plans, Drug Manufacturers, and the Federal GovernmentErin Trish, Katrina M Kaiser, Jeanai Celestin, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
JAMA Network Open|January 26, 2021
Association of Out-of-Pocket Spending With Insulin Adherence in Medicare Part DErin Trish, Katrina Kaiser, Geoffrey Joyce
Health Affairs (Project Hope)|November 5, 2014
Specialty drug spending trends among Medicare and Medicare Advantage enrollees, 2007-11Erin Trish, Geoffrey Joyce, Dana P Goldman
JAMA Network Open|August 1, 2025
Formulary Restrictions and Relapse Episodes in Persons With Relapsing-Remitting Multiple SclerosisBarbara Blaylock, Karen Van Nuys, Geoffrey Joyce
Obstetrics and Gynecology|March 23, 2011
Association between the birth of twins and parental divorceAnupam B Jena, Dana P Goldman, Geoffrey Joyce
Kidney International|September 17, 2005
Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?Christopher S Saigal, Geoffrey Joyce, Anga R Timilsina, et al.
The American Journal of Managed Care|August 18, 2017
The price may not be right: the value of comparison shopping for prescription drugsSanjay Arora, Neeraj Sood, Sophie Terp, et al.
The American Journal of Managed Care|October 17, 2022
Formulary restrictions and stroke risk in patients with atrial fibrillationBo Zhou, Seth Seabury, Dana Goldman, et al.
JAMA Internal Medicine|July 11, 2017
Physician Reimbursement in Medicare Advantage Compared With Traditional Medicare and Commercial Health InsuranceErin Trish, Paul Ginsburg, Laura Gascue, et al.
Health Affairs (Project Hope)|March 4, 2024
Medicare Part D Plans Greatly Increased Utilization Restrictions On Prescription Drugs, 2011-20Geoffrey Joyce, Barbara Blaylock, Jiafan Chen, et al.
Journal of Health Politics, Policy and Law|July 22, 2022
Reforming the Medicare Part D Benefit Design: Financial Implications for Beneficiaries, Private Plans, Drug Manufacturers, and the Federal GovernmentErin Trish, Katrina M Kaiser, Jeanai Celestin, et al.
Pageof 5